Tigermed Receives 2020
Chinese CRO Customer
Value Leadership Award
By Frost & Sullivan Best Practices Award
For Better Research
We are committed to supporting our clients in their clinical development in the best possible way. As the leading clinical Contract Research Organization (CRO) in China, we are dedicated to provide services for new drug research and development and other supporting services to global and Chinese pharmaceutical and biotechnology companies. Since our inception in 2004, Tigermed has always embraced new technologies and partnerships to accelerate product development and generate the clinical evidence that our clients require to demonstrate real-world value.
Message from Our Chairman
At Tigermed we take pride in the work we do, thanks to the clear goal of providing our clients with clinical development support that facilitates accelerated drug development, eventually saving lives.
Dr. Xiaoping Ye
Ph.D. / MD / EMBA / Co-Founder / Chairman
Facts about Tigermed
Tigermed is a rapidly growing company. Besides growing the number of global locations and colleagues, we are also continously expanding our areas of expertise to address unmet patient needs.
*As of Q1 2020
Innovative Drug Projects
Global Service Locations
“I don’t know how you do it. You guys are our strategic partner, have always delivered on time and accurately over the last 10 years we have worked together. You outperform all the other biometrics CROs we work with. That is why we continue to give you more business.”
Head of Biometrics
at one of the top 10 global pharma companies in US
Keeping Up with
We have always embraced the latest technology and strived to be a thought leader in clinical research. For this reason we are known as the Innovative CRO in China.
As the leading CRO in China, we are uniquely positioned to support you in entering the Chinese pharmaceutical market which is rapidly emerging and offers many unmet patient needs.
Click on each topic to learn more
Our scientific staff applies proven techniques and best-in-class approaches to generate data for critical milestones and decision making during drug discovery and development.
- Drug Metabolism and Pharmacokinetics (DMPK)
- Toxicology Services to guide new therapies from discovery to full development
- Bioanalytical Services to help the molecule to the market
- CMC (Chemistry, Manufacturing, and Control) Services to support formulation to the pharmacy
- BE Study to support for international customers seeking to make applications for approval in the United States
Regulatory Submission & Approval
Our regulatory experts have years of experiences with the FDA, NMPA, and the EU health authorities and are familiar with differences in local regulatory requirements. They can provide you with feasible strategies and act as liaison with various regulatory agencies, both on technical and regulatory issues.
Early Clinical Development
Our teams collaborate closely with you to develop tailored roadmaps for your study and aim to maximize efficiency, anticipate challenges, and mitigate risk. Our phase I strategies to minimize the time spent on reaching a key go/no-go decision by leveraging our many clinical facilities, biometrics capabilities, PK/PD study experts, and project management experience. This Is all part of the Integrated Technology Services that Tigermed has developed to ensure rapid and high-quality data collection, analysis, and reporting to the benefit of our clients’ clinical development programs.
We always start with the end in mind and successful studies should have a high degree of flexibility as to answer questions early to avoid unnecessary investment at later stage. Answering these meaningful questions in modern clinical trials is facilitated by our advanced skillset in biometrics to help you generate the clinical evidence you need. Additionally, we have a proven track-record of enrolling suitable and usually hard-to-find patients for specialized trials thanks to our dedicated recruitment centers.
Integrated Technology Services
By combining our professional knowledge and Tigermed’s technical capabilities we are able to offer complete solutions throughout the entire clinical trial. And, by integrating our full services chain in clinical research, we are able to help our clients save both time and costs.
Late Phase Development
These sheer size of large trials means increasingly complex study designs, evermore challenging subject enrollment, and demand for therapeutic knowledge. Modern successful trials implement adaptive clinical trial designs, make use of experienced clinical operations staff, advanced PK/PD and biometrics, all of which Tigermed has to offer tailored into a solution that fits your needs.
By making use of our robust in-house quality management system, well-developed SOPs, extensive experience in international project management, we have executed numerous large-scale trials efficiently and cost-effectively.
Post-Marketing / Real World Data
The use of real-world data is growing rapidly in clinical development. With our in-house capabilities we can help you turn this real-world data into real-world clinical evidence.
Tigermed has established a global service network. Utilizing our trial services helps broaden the scope of our clients’ clinical development and subsequently delivers the most value from their products with the optimal balance of quality, speed and efficiency.
Stay Connected with Tigermed
Sign up to receive our newsletter on hands-on expertise, industry news, changing legislation and tips on practical solutions to industry challenges.
Meet Us at Upcoming Events